Graf Akcie TRIB (Trinity Biotech Plc). Diskuze k akciím TRIB. Aktuální informace TRIB.

Základní informace o společnosti Trinity Biotech Plc (Akcie TRIB)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace
Hodnota podniku (EV)
Tržby
EBITDA
Zisk
Růst v tržbách Q/Q %
Růst v tržbách Y/Y %
P/E (Cena vůči ziskům)
Forward P/E
EV/Sales
EV/EBITDA
EV/EBIT
PEG
Price/Sales
P/FCF
Price/Book
Účetní hodnota na akcii
Hotovost na akcii
FCF vůči ceně %
Počet zaměstnanců
Tržba na zaměstnance
Profit margin %
Operating margin %
Gross margin %
EBIT margin %
EBITDA margin %
EPS - Zisk na akcii
EPS - Kvartální růst %
EPS - Očekávaný růst příští rok %
Return on assets %
Return on equity %
ROIC %
ROCE %
Dluhy/Equity
Čistý dluh/EBITDA
Current ratio
Quick Ratio
Volatilita
Beta
RSI
Cílová cena analytiků
Známka akcie (dle analytiků)
Insider ownership %
Institutional ownership %
Počet akcií
Procento shortovaných akcií %
Short ratio %
Dividenda
Procentuální dividenda %
Dividenda/Zisk %
Obchodovaná od
Země

Finanční výsledky akcie TRIB

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$90.435$97.035$99.14$99.611$100.195$104.872
Cost Of Goods Sold$52.315$55.586$57.25$56.127$53.683$55.496
Gross Profit$38.12$41.449$41.89$43.484$46.512$49.376
Research And Development Expenses$5.325$5.369$5.657$5.04$5.069$4.291
SG&A Expenses$32.703$29.477$74.001$78.531$28.225$30.071
Other Operating Income Or Expenses$-24.204$-26.83$0.1$0.239$0.288$0.424
Operating Expenses$114.547$117.262$136.808$139.459$86.689$89.434
Operating Income$-24.112$-20.227$-37.668$-39.848$13.506$15.438
Total Non-Operating Income/Expense$-5.885$-2.956$-2.207$-2.292$9.437$-0.035
Pre-Tax Income$-29.997$-23.183$-39.875$-42.14$22.943$15.403
Income Taxes$-1.006$-0.525$-1.214$-3.557$0.756$0.479
Income After Taxes$-28.991$-22.658$-38.661$-38.583$22.187$14.924
Other Income------
Income From Continuous Operations$-28.991$-22.658$-38.661$-38.583$22.187$14.924
Income From Discontinued Operations$0.077$0.568$-1.609$-62.042$-0.391$2.29
Net Income$-28.914$-22.09$-40.27$-100.625$21.796$17.214
EBITDA$-19.218$-16.106$-32.469$-33.716$19.148$19.933
EBIT$-24.112$-20.227$-37.668$-39.848$13.506$15.438
Basic Shares Outstanding212122232323
Shares Outstanding252627282724
Basic EPS$-1.38$-1.06$-1.86$-4.38$0.94$0.76
EPS - Earnings Per Share$-1.38$-1.06$-1.86$-4.38$0.46$0.73
# 2020 2019 2018 2017 2016 2015
Current Ratio3.67064.92285.30365.28048.10283.1258
Long-term Debt / Capital0.95490.65030.58910.46090.302-
Debt/Equity Ratio21.67831.86921.43940.85750.434-
Gross Margin42.151842.715542.253443.653846.421547.0822
Operating Margin-26.6623-20.8451-37.9948-40.003613.479714.7208
EBIT Margin-26.6623-20.8451-37.9948-40.003613.479714.7208
EBITDA Margin-21.2506-16.5981-32.7507-33.847719.110719.007
Pre-Tax Profit Margin-33.1697-23.8914-40.2209-42.304622.898414.6874
Net Profit Margin-31.9721-22.765-40.6193-101.01821.753616.4143
Asset Turnover0.690.63980.51370.39910.27550.4319
Inventory Turnover Ratio1.63381.8311.74521.72231.52831.6558
Receiveable Turnover4.30913.97024.78014.41053.91364.0373
Days Sales In Receivables84.704591.935576.357782.757293.265490.4077
ROE - Return On Equity-615.1287-51.4323-59.2996-35.486110.3737.5767
Return On Tangible Equity74.4485254.6699-8746.806-179.857542.233628.7287
ROA - Return On Assets-22.1186-14.9401-20.0343-15.45846.10066.1457
ROI - Return On Investment-27.7482-17.988-24.3637-19.12987.24017.5767
Book Value Per Share0.1961.83252.71194.52268.9278.3544
Operating Cash Flow Per Share-0.0667-0.0647-0.0173-0.1186-0.19710.2777
Free Cash Flow Per Share0.1405-0.1757-0.0484-0.0087-0.10720.1206